Alcon, the eye care unit of Swiss drug major Novartis, will locate its future global headquarters in the Canton of Geneva.
UK biotechnology company Albumedix has entered into a collaborative agreement with Novartis
Gene therapy company Abeona Therapeutics has opened the Elisa Linton Center for Rare Disease Therapies.
Generics drug manufacturer Apotex and India’s pharmaceutical company Strides Shasun are merging their Australian businesses.